Company / Current Assets per Share
TherapeuticsMD, Inc. Current Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.06
FY2024
5-year range
$0.40 / $6.44
FY2020-FY2024
Trend
-14.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has fluctuated over the past 10 years, ranging from $0.40 in FY2021 to $6.44 in FY2022.
Based on SEC 10-K filings.
1.06 in FY2024 with a 5-year CAGR of +4.2%.
Declined from $6.44 to $1.06 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +38.7%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, current assets per share decreased 14.4% year-over-year.
- Peak current assets per share was recorded in FY2022.
- Lowest current assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.06 | -14.4% |
| FY2023 | $1.24 | -80.7% |
| FY2022 | $6.44 | +1515.3% |
| FY2021 | $0.40 | -15.8% |
| FY2020 | $0.47 | -45.4% |
| FY2019 | $0.87 | +0.4% |
| FY2018 | $0.86 | +21.6% |
| FY2017 | $0.71 | -9.4% |
| FY2016 | $0.78 | +60.7% |
| FY2015 | $0.49 | +25.7% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026